Bayer Q3 Results - Q3 Top Pharma Company Earnings Reports

View Bayer's Q3 Earnings Report


  • Bayer HealthCare posted another strong performance in the third quarter, with earnings up by a double-digit percentage.
  • Sales of the subgroup rose by 3.5 percent (Fx & portfolio adj. 4.2 percent) to EUR 3,936 million (Q3 2008: EUR 3,802 million).
  • The Pharmaceuticals segment raised sales by 3.0 percent (Fx & portfolio adj. 3.8 percent) to EUR 2,548 million, performing especially well in Asia and Latin America

Check out Pfizer's current earnings estimates from CNN Money

Bayer's Website:

Bayer Q3 Results - Q3 Top Pharma Company Earnings Reports

Suggested Articles

Dogged by opioid liabilities, Mallinckrodt is reportedly looking to restructure its U.S. generics unit to cover its debts and possible settlements.

Novartis has touted early success for its new eye drug Beovu, but an alert tying the drug to potential vision loss might cause docs to balk.

Sanofi will unload six manufacturing sites and 3,100 employees into a new API production company as it looks for €2 billion in cost savings.